VTGN today

$0.18+$0.00 (+0.95%)close Nov 13, 2026

Trend

DailyDowntrend (confirmed)

4 hourStrong Bullish

1 hourExpanding

15 minLeaning Bearish

5 minConsolidating

Daily trend turns up above $0.19

Key levels

Resistance$0.22

Resistance$0.19

Support$0.16

About Vistagen Therapeutics

Vistagen Therapeutics is a clinical-stage biopharmaceutical company developing intranasal therapies for central nervous system conditions. Its pipeline includes fasedienol for social anxiety disorder, itruvone for major depressive disorder, refisolone for menopausal hot flashes and premenstrual dysphoric disorder, PH15 for psychomotor impairment from mental fatigue, and PH284 for cancer cachexia. The company also has an oral candidate, AV-101, for neurological disorders involving the NMDAR. It operates in the United States and has conducted clinical studies in Mexico.

Based on the company's 10-K filed Jun 15, 2026.

Nasdaq · Healthcare

Vistagen Therapeutics, Inc. (VTGN)

$0.18+0.00 (+0.95%)

HOLDGrade: CRisk: LOW

1D 5D1M1Y 5Y MaxSign up for all timeframes

High0.18

Low0.18

Open0.18

Volume376K

Avg Vol762K

VWAP0.18

30d High0.26

30d Low0.16

30d Chg-31.42%

See full chart with real-time data

What Is the Price Target for VTGN?

SEPT Low Target

$0.00

SEPT Mid Target

$0.00

SEPT High Target

$0.00

Analyst Consensus

$0.00

Current: $0.18Upside: +0.0%Confidence: 20%Method: No Coverage

Is VTGN a Buy or Sell Right Now?

Investability Score

HOLD12-18 months

Thesis

•Revenue growing 161.1% YoY with ACCELERATING trend — accelerating momentum.

AI-Powered Trading Signals

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy for VTGN.

Start Free Trial →

Is VTGN Overvalued or Undervalued?

Valuation Verdict

UNDERVALUED

Methods Used

P/B

Fair Value

$1.44

Moat Score

NONE

2/9

Piotroski Score

-17.5

Altman Z-Score

What Is Smart Money Doing with VTGN?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

MEDIUM

Signal: NEUTRAL

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See All Smart Money Signals →

VTGN Growth Story

Revenue YoY

161.1%

3yr Revenue CAGR

4.6%

EPS Growth YoY

-9.58%

FCF Growth YoY

N/A%

Revenue Trend

ACCELERATING

Dark Pool Trades for VTGN

PREVIEW

SEPT Investing tracks real-time dark pool institutional trades for VTGN, including block trade sizes, dollar values, and buy/sell side classification. Dark pool trades reveal where institutional investors are positioning before moves become visible on public exchanges.

Time	Price	Size	Value	Side
21:26:21	$0.19	1,000	$$185	BUY
20:59:51	$0.18	2,296	$$415	BUY
20:57:40	$0.18	5,000	$$902	BUY
20:57:25	$0.18	5,000	$$902	BUY
20:51:30	$0.18	5,000	$$904	BUY

5 dark pool trades shown · $$3K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

What Traders Are Saying About VTGN

1 posts

SEPT Investing hosts an active community of 3,500+ traders sharing real-time analysis, trade setups, and market discussion for VTGN. Join verified traders discussing price action, dark pool alerts, options flow, and AI-powered market intelligence.

Jason2d ago

$VTGN earnings are due on Thu Nov 12.

24 views

Join 3,500+ traders discussing VTGN in real-time

Trade ideas, setups, dark pool alerts, and AI-powered analysis

Join the discussion

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Vistagen Therapeutics, Inc. (VTGN) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (3 articles analyzed), and SEC filing intelligence...

AI-Powered Trading Signals.

Trained on trillions of real market data to read price action and give you a simple, emotionless trading strategy. SEPT tells you when to buy, when to sell, and grades every stock so you never trade blind.

Try SEPT Free for 7 Days →

VTGN — frequently asked questions

What is VTGN stock price today?

Vistagen Therapeutics, Inc. (VTGN) is at $0.18, up 0.95% (+$0.00) at the Nov 13, 2026 close.

Why is VTGN stock moving today?

Latest VTGN news — Nov 13, 2026: Vistagen Therapeutics, Inc. filed a report on a major company event (Form 8-K) · Nov 13, 2026: VistaGen Therapeutics posts smaller quarterly loss but revenue falls short

What do analysts rate VTGN?

Analyst ratings for VTGN: 0 Buy, 4 Hold, 0 Sell — consensus Hold.

Did VTGN beat earnings?

VTGN last reported on Aug 14, 2026: EPS -$0.30 vs -$0.36 expected — a beat of 17.8%.

What are VTGN support and resistance levels?

Support: $0.16. Resistance: $0.19, $0.22, $0.23.

What are insiders doing with VTGN?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on VTGN?

Nov 13, 2026: Vistagen Therapeutics, Inc. filed a report on a major company event (Form 8-K) · Nov 13, 2026: VistaGen Therapeutics posts smaller quarterly loss but revenue falls short · Nov 9, 2026: Vistagen issues regulatory update after FDA discussion on fasedienol